Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Total Debt / Equity

Nymox Pharm Corp Total Debt / Equity Chart (NYMX)

Nymox Pharm Corp annual/quarterly Total Debt / Equity from 2014 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Nymox Pharm Corp Total Debt / Equity for the quarter ending June 06, 2020 was $-15m a 125.67% decrease of -19m year over year
  • Nymox Pharm Corp Total Debt / Equity for the last 12 months ending June 06, 2020 was $-15m a 125.67% decrease of -19m year over year
  • Nymox Pharm Corp Annual Total Debt / Equity for 2019 was $4m a 9,161.22% increase of 391m from 2018
  • Nymox Pharm Corp Annual Total Debt / Equity for 2016 was $-386m a 91.04% decrease of -352m from 2015
  • Nymox Pharm Corp Annual Total Debt / Equity for 2015 was $-35m a 45.04% decrease of -16m from 2014
Other Ratios Metrics:
  • Nymox Pharm Corp Total Debt / Capital for the quarter ending September 09, 2017 was $98m a 78.16% increase of 77m year over year
  • Nymox Pharm Corp Other Liabilities for the quarter ending December 12, 2016 was $0m a 208,053.10% decrease of -2m year over year
View Chart On Koyfin

Quarterly NYMX Total Debt / Equity Data

06/2020$-15m
03/2020$16m
12/2019$4m
09/2019$4m
06/2019$4m
03/2019$3m
09/2017$6,192m
06/2017$-91m
03/2017$-82m
12/2016$-386m

Annual NYMX Total Debt / Equity Data

2019$4m
2016$-386m
2015$-35m
2014$-19m